Normal view MARC view ISBD view

A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501

Richard Markus et al

A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501

Subjects--Topical Terms:
Computer science, information & general works

Place hold
Print
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)